Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix)

Ching Hui Chen, Wen Ling Lee, I. Te Wang, Yuan Kuei Yen, Li Hsuan Chiu, Chii-Ruey Tzeng, Wei-Min Liu

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)


Objectives: The safety and efficacy of the RevoLix 2-μ continuous wave laser for hysteroscopic myomectomy (HM) was evaluated. Materials and methods: A retrospective study was undertaken to evaluate 13 patients with symptomatic submucous myomas, who were treated with HM using a RevoLix laser application. The evaluation items included blood loss from surgery (estimated by the change between preoperative and postoperative hemoglobin levels), surgical time, amount of distension media, specimen volume retrieved, complications, and success rate. Results: The mean age of the patients was 38 years old; 10 patients were in the premenopausal status and nine patients were nullipara. The surgical time was 91 minutes, and the distension media requirement was 4500mL. The postoperative hemoglobin level decreased to 1.2g/dL compared with the preoperative status. Mean specimen volume retrieved was 13.7mm. No complications occurred. All patients reported significant improvement after HM during the 1-year follow-up. Conclusion: The use of the Revolix laser for HM seemed to be safe and effective in the management of symptomatic submucous myomas in this small population study.
頁(從 - 到)89-92
期刊Gynecology and Minimally Invasive Therapy
出版狀態已發佈 - 8月 2013

ASJC Scopus subject areas

  • 婦產科


深入研究「Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix)」主題。共同形成了獨特的指紋。